Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gynecol Oncol Rep ; 17: 20-2, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27354995

ABSTRACT

Sister Mary Joseph's nodule is sometimes the first sign of an internal malignancy, including gastrointestinal, gynecological, or malignancy of unknown primary. It is rarely the sole presentation of a primary peritoneal cancer. In this report, we present the case of a 70-year-old female with umbilical drainage and a computed tomography scan consistent with solitary umbilical nodule. Excision of the nodule revealed adenocarcinoma of likely müllerian origin. Surgical staging did not show any evidence of malignancy with the exception of pelvic washings. She was considered to have primary peritoneal adenocarcinoma and was treated with adjuvant chemotherapy.

2.
Obstet Gynecol ; 123(2 Pt 2 Suppl 2): 465-468, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24413227

ABSTRACT

BACKGROUND: Müllerian agenesis is a congenital malformation characterized by absence of the uterus, cervix, and upper vagina. A positive home pregnancy test in a woman with Müllerian agenesis mandated evaluation for malignancy. CASE: A woman with Müllerian agenesis presented with elevated levels of human chorionic gonadotropin (hCG), testosterone, and dehydroepiandrosterone sulfate. Pelvic magnetic resonance imaging (MRI), abdominal and pelvic computed tomography scan, chest computed tomography scan, brain MRI, and body positron emission tomography scan did not identify a malignancy. Human chorionic gonadotropin characterization revealed 74% hyperglycosylated and 1.6% free ß-hCG, suggesting a trophoblast-containing tumor. Interventional ovarian venous sampling and repeat pelvic MRI suggested a right adnexal source. After laparoscopic removal of a stage 1C right ovarian dysgerminoma, hCG and testosterone returned to normal. CONCLUSION: A dysgerminoma coincident with Müllerian agenesis expressed hCG before detection by MRI. Human chorionic gonadotropin molecular characterization, ovarian vein sampling, and repeat pelvic MRI led to successful treatment.


Subject(s)
46, XX Disorders of Sex Development/blood , Chorionic Gonadotropin/blood , Congenital Abnormalities/blood , Dysgerminoma/blood , Hyperandrogenism/etiology , Mullerian Ducts/abnormalities , Ovarian Neoplasms/blood , Chorionic Gonadotropin/biosynthesis , Dysgerminoma/complications , Female , Humans , Ovarian Neoplasms/complications , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...